Published in J Surg Res on April 01, 2012
Inflammatory mediators in vascular disease: identifying promising targets for intracranial aneurysm research. Mediators Inflamm (2015) 0.82
Donor-specific tolerance induction in organ transplantation via mixed splenocytes chimerism. Clin Exp Immunol (2013) 0.75
CD4+CD25+ T regulatory cell-depleted splenocytes enhance chimerism in graft recipients. J Surg Res (2012) 0.75
Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol (2003) 6.14
Prognostic impact of anatomic resection for hepatocellular carcinoma. Ann Surg (2005) 4.13
One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg (2003) 3.84
Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma. Eur J Cancer (2011) 2.81
Marginal survival benefit in the treatment of early hepatocellular carcinoma. J Hepatol (2012) 2.77
Surgical resection vs. percutaneous ablation for hepatocellular carcinoma: a preliminary report of the Japanese nationwide survey. J Hepatol (2008) 2.64
Delta1-Notch3 interactions bias the functional differentiation of activated CD4+ T cells. Immunity (2003) 2.34
Prophylactic impact of endoscopic treatment for esophageal varices in liver resection: a prospective study. J Gastroenterol (2013) 2.08
Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma. Ann Surg (2003) 2.01
Chinese herbal medicines as adjuvant treatment during chemo- or radio-therapy for cancer. Biosci Trends (2010) 2.01
Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate. Ann Surg (2003) 2.00
FLOWERING LOCUS T regulates stomatal opening. Curr Biol (2011) 1.97
Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan. Hepatol Res (2008) 1.91
Phase I trial of a glypican-3-derived peptide vaccine for advanced hepatocellular carcinoma: immunologic evidence and potential for improving overall survival. Clin Cancer Res (2012) 1.84
Acute Appendicitis in an Incarcerated Femoral Hernia: A Case of De Garengeot Hernia. Case Rep Gastroenterol (2009) 1.67
Failure patterns in patients with esophageal cancer treated with definitive chemoradiation. Cancer (2011) 1.66
Intractable and rare diseases research in Asia. Biosci Trends (2012) 1.59
Clinical significance of extrahepatic bile duct resection for advanced gallbladder cancer. J Surg Oncol (2006) 1.56
Combined hepatocellular and cholangiocarcinoma: a clinicopathologic study of 26 resected cases. Jpn J Clin Oncol (2003) 1.50
Transfusion criteria for fresh frozen plasma in liver resection: a 3 + 3 cohort expansion study. Arch Surg (2011) 1.50
Evaluation of hepatic venous congestion: proposed indication criteria for hepatic vein reconstruction. Ann Surg (2002) 1.43
Systemic administration of IL-23 induces potent antitumor immunity primarily mediated through Th1-type response in association with the endogenously expressed IL-12. J Immunol (2007) 1.40
Endoscopic prediction of hepatocellular carcinoma by evaluation of bleeding esophageal varices. Digestion (2004) 1.39
Antitumor activity of extracts and compounds from the skin of the toad Bufo bufo gargarizans Cantor. Int Immunopharmacol (2010) 1.38
Prognostic factors of surgical resection in middle and distal bile duct cancer: an analysis of 55 patients concerning the significance of ductal and radial margins. Surgery (2005) 1.32
Outcomes after emergency surgery for gastric perforation or severe bleeding in patients with gastric cancer. J Surg Oncol (2002) 1.31
Emerging concepts in biomarker discovery; the US-Japan Workshop on Immunological Molecular Markers in Oncology. J Transl Med (2009) 1.31
Bufalin and cinobufagin induce apoptosis of human hepatocellular carcinoma cells via Fas- and mitochondria-mediated pathways. Cancer Sci (2011) 1.28
Evidence-based Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2013 update (3rd JSH-HCC Guidelines). Hepatol Res (2015) 1.23
Evaluation of serum CEA and CA19-9 levels as prognostic factors in patients with gastric cancer. Gastric Cancer (2000) 1.21
Management of perforated gastric carcinoma: a report of 16 cases and review of world literature. Am Surg (2002) 1.19
Expression of L-type amino acid transporter 1 (LAT1) in esophageal carcinoma. J Surg Oncol (2005) 1.17
alpha-Fetoprotein mRNA in the circulation as a predictor of postsurgical recurrence of hepatocellular carcinoma: a prospective study. Hepatology (2002) 1.16
Milk fat globule epidermal growth factor-8 blockade triggers tumor destruction through coordinated cell-autonomous and immune-mediated mechanisms. J Exp Med (2009) 1.15
Management of hepatocellular carcinoma: Report of Consensus Meeting in the 45th Annual Meeting of the Japan Society of Hepatology (2009). Hepatol Res (2010) 1.11
Pringle's manoeuvre in living donors. Lancet (2002) 1.08
Cinobufacini, an aqueous extract from Bufo bufo gargarizans Cantor, induces apoptosis through a mitochondria-mediated pathway in human hepatocellular carcinoma cells. J Ethnopharmacol (2010) 1.08
Collision tumor of the stomach: a rare case of an adenocarcinoma and carcinoid tumor. Arch Pathol Lab Med (2005) 1.07
Mortality for gastric cancer in elderly patients. J Surg Oncol (2003) 1.05
Biomarkers: evaluation of screening for and early diagnosis of hepatocellular carcinoma in Japan and china. Liver Cancer (2013) 1.05
Reduced transforming growth factor-beta receptor II expression in hepatocellular carcinoma correlates with intrahepatic metastasis. Lab Invest (2010) 1.04
The management of hepatocellular carcinoma around the world: a comparison of guidelines from 2001 to 2011. Liver Int (2012) 1.04
p16INK4A hypermethylation is associated with hepatitis virus infection, age, and gender in hepatocellular carcinoma. Clin Cancer Res (2004) 1.01
Recent advances in chemotherapy for advanced gastric cancer in Japan. Surg Today (2010) 1.00
Uracil-tegafur as an adjuvant for hepatocellular carcinoma: a randomized trial. Hepatology (2006) 1.00
Right lateral sector graft in adult living-related liver transplantation. Transplantation (2002) 1.00
Inhibition of MMP-9 transcription and suppression of tumor metastasis by pyrrole-imidazole polyamide. Cancer Sci (2009) 1.00
Stimulation of angiogenesis, neurogenesis and regeneration by side population cells from dental pulp. Biomaterials (2012) 1.00
Identification of substituted pyrimido[5,4-b]indoles as selective Toll-like receptor 4 ligands. J Med Chem (2013) 0.99
Programmed death-1-programmed death-L1 interaction is essential for induction of regulatory cells by intratracheal delivery of alloantigen. Transplantation (2004) 0.99
Value of highly sensitive fucosylated fraction of alpha-fetoprotein for prediction of hepatocellular carcinoma recurrence after curative treatment. Dig Dis Sci (2013) 0.98
Fungal metabolite gliotoxin blocks mast cell activation by a calcium- and superoxide-dependent mechanism: implications for immunosuppressive activities. Clin Immunol (2005) 0.98
New insights into the regulation of stomatal opening by blue light and plasma membrane H(+)-ATPase. Int Rev Cell Mol Biol (2011) 0.98
Celiac node failure patterns after definitive chemoradiation for esophageal cancer in the modern era. Int J Radiat Oncol Biol Phys (2012) 0.98
Sera from liver failure patients and a demethylating agent stimulate transdifferentiation of murine bone marrow cells into hepatocytes in coculture with nonparenchymal liver cells. J Hepatol (2003) 0.97
An evaluation of the effectiveness of extended lymph node dissection in patients with gastric cancer: a retrospective study of 1403 cases at a single institution. J Surg Res (2002) 0.97
FLEP chemotherapy for alpha-fetoprotein-producing gastric cancer. Oncology (2004) 0.97
Isolated tuberculous liver abscess invading the abdominal wall: report of a case. Surg Today (2011) 0.97
Applications and bioefficacy of the functional food supplement fermented papaya preparation. Toxicology (2010) 0.95
Distinct gene expression of osteopontin in patients with ulcerative colitis. J Surg Res (2003) 0.95
Effectiveness of hepatic resection for early-stage hepatocellular carcinoma in cirrhotic patients: subgroup analysis according to Milan criteria. Jpn J Clin Oncol (2007) 0.95
A comparison of the surgical outcomes among patients with HBV-positive, HCV-positive, and non-B non-C hepatocellular carcinoma: a nationwide study of 11,950 patients. Ann Surg (2015) 0.94
Induction of apoptosis by cinobufacini preparation through mitochondria- and Fas-mediated caspase-dependent pathways in human hepatocellular carcinoma cells. Food Chem Toxicol (2011) 0.94
Progress in surgical treatment of hepatocellular carcinoma. Oncology (2002) 0.93
Current approaches to the treatment of early hepatocellular carcinoma. Oncologist (2010) 0.93
Safe donor hepatectomy for living related liver transplantation. Liver Transpl (2002) 0.93
Anti-hepatitis B virus activities of cinobufacini and its active components bufalin and cinobufagin in HepG2.2.15 cells. Biol Pharm Bull (2010) 0.93
Clinical significance of early hepatocellular carcinoma. Liver Transpl (2004) 0.93
Bacterial neuraminidase rescues influenza virus replication from inhibition by a neuraminidase inhibitor. PLoS One (2012) 0.92
Macroscopic portal vein tumor thrombi of liver metastasis from colorectal cancer. J Hepatobiliary Pancreat Surg (2008) 0.92
Gd-EOB-DTPA-enhanced magnetic resonance imaging and alpha-fetoprotein predict prognosis of early-stage hepatocellular carcinoma. Hepatology (2014) 0.92
Selective cyclooxygenase 2 inhibitor induces indefinite survival of fully allogeneic cardiac grafts and generates CD4+ regulatory cells. J Thorac Cardiovasc Surg (2005) 0.92
D2 gastrectomy with versus without bursectomy for gastric cancer. Am J Clin Oncol (2014) 0.92
Clinical significance of subcellular localization of KL-6 mucin in primary colorectal adenocarcinoma and metastatic tissues. World J Gastroenterol (2006) 0.91
Clinical utility of simultaneous measurement of alpha-fetoprotein and des-γ-carboxy prothrombin for diagnosis of patients with hepatocellular carcinoma in China: A multi-center case-controlled study of 1,153 subjects. Biosci Trends (2014) 0.91
Neoadjuvant chemotherapy with S-1 and CDDP in advanced gastric cancer. J Cancer Res Clin Oncol (2006) 0.91
Perspectives on human clinical trials of therapies using iPS cells in Japan: reaching the forefront of stem-cell therapies. Biosci Trends (2013) 0.91
The use of granulocyte-colony stimulating factor induced mobilization for isolation of dental pulp stem cells with high regenerative potential. Biomaterials (2013) 0.90
Association between pretransplant psychological assessments and posttransplant psychiatric disorders in living-related transplantation. Psychosomatics (2002) 0.90
Endovascular stenting for celiac axis stenosis before pancreaticoduodenectomy. Surgery (2003) 0.89
Presence of two glycolytic gene clusters in a severe pathogenic line of Candidatus Phytoplasma asteris. Mol Plant Pathol (2007) 0.89
Multistep and multicentric development of hepatocellular carcinoma: histological analysis of 980 resected nodules. J Hepatol (2005) 0.89
Nomograms for prognostication of outcome in patients with esophageal and gastroesophageal carcinoma undergoing definitive chemoradiotherapy. Oncology (2012) 0.89
Impaired volume regeneration of split livers with partial venous disruption: a latent problem in partial liver transplantation. Transplantation (2002) 0.89
Photodynamic therapy for human hepatoma-cell-line tumors utilizing biliary excretion properties of indocyanine green. J Gastroenterol (2013) 0.89
Bioresorbable membrane to reduce postoperative small bowel obstruction in patients with gastric cancer: a randomized clinical trial. Ann Surg (2008) 0.89
Interleukin-10 but not transforming growth factor-beta is essential for generation and suppressor function of regulatory cells induced by intratracheal delivery of alloantigen. Transplantation (2005) 0.88
Resection of solitary metachronous lymph node metastasis from hepatocellular carcinoma following transarterial chemotherapy with cisplatin: a case report. Anticancer Res (2011) 0.88
Effect of gastrectomy on the pharmacokinetics of S-1, an oral fluoropyrimidine, in resectable gastric cancer patients. Cancer Chemother Pharmacol (2007) 0.88
Role of splenectomy in living-donor liver transplantation for adults. Hepatogastroenterology (2002) 0.88
Caudate lobectomy (segmentectomy 1) (with video). J Hepatobiliary Pancreat Sci (2012) 0.87